168 related articles for article (PubMed ID: 23001618)
1. Functional MR cholangiography of the cystic duct and sphincter of Oddi using gadoxetate disodium: is a 30-minute delay long enough?
Corwin MT; Lamba R; McGahan JP
J Magn Reson Imaging; 2013 Apr; 37(4):993-8. PubMed ID: 23001618
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the gallbladder and cystic duct patency with gadoxetate disodium enhanced MR cholangiography: prospective comparison of patients with normal gallbladder function and acute cholecystitis.
Yacoub JH; Yousuf A; Agrawal G; Thomas S; Appelbaum DE; Oto A
Acta Radiol; 2015 Jul; 56(7):782-9. PubMed ID: 25009279
[TBL] [Abstract][Full Text] [Related]
3. Determination of cystic duct patency using hepatobiliary MRI with gadoxetate disodium: is T1 precontrast imaging necessary?
Corwin MT; Karam AR; Baker SP; Kim YH
J Magn Reson Imaging; 2012 Mar; 35(3):601-6. PubMed ID: 22034256
[TBL] [Abstract][Full Text] [Related]
4. Gd-EOB-DTPA as a functional MR cholangiography contrast agent: imaging gallbladder filling in patients with and without hepatobiliary dysfunction.
Smith AD; Veniero JC
J Comput Assist Tomogr; 2011; 35(4):439-45. PubMed ID: 21765298
[TBL] [Abstract][Full Text] [Related]
5. MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography?
Reiner CS; Merkle EM; Bashir MR; Walle NL; Nazeer HK; Gupta RT
AJR Am J Roentgenol; 2013 Jul; 201(1):W49-56. PubMed ID: 23789696
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal?
Ringe KI; Husarik DB; Gupta RT; Boll DT; Merkle EM
Eur J Radiol; 2011 Aug; 79(2):201-5. PubMed ID: 20347540
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of optimal scan delay for gadoxetate disodium-enhanced hepatic arterial phase MRI using MR fluoroscopic triggering and slow injection technique.
Goshima S; Kanematsu M; Kondo H; Watanabe H; Kawada H; Moriyama N; Bae KT
AJR Am J Roentgenol; 2013 Sep; 201(3):578-82. PubMed ID: 23971449
[TBL] [Abstract][Full Text] [Related]
8. Gallbladder opacification on gadoxetate disodium-enhanced CT scan.
Karam AR; Scortegagna E; Chen BY; Dupuis CS; Coughlin DD
Emerg Radiol; 2017 Apr; 24(2):139-142. PubMed ID: 27807654
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cystic duct patency: comparison of functional MR cholangiography with gadoxetate disodium and hepatobiliary scintigraphy in suspected acute cholecystitis.
Corwin MT; Malutich S; Salcedo ES; Fananapazir G; Brock JM; McGahan JP
Clin Imaging; 2016; 40(5):973-8. PubMed ID: 27240319
[TBL] [Abstract][Full Text] [Related]
10. Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable?
Ringe KI; Gupta RT; Brady CM; Massey CM; Hahn A; Galanski M; Merkle EM; Lotz J
Radiology; 2010 May; 255(2):451-8. PubMed ID: 20413758
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of gadoxetate disodium-enhanced MR cholangiography in chronic cholestatic biliary disease.
Kühn JP; Spoerl M; Nassif A; Mester M; Weitschies W; Siegmund W; Hosten N; Mensel B
Clin Radiol; 2014 Oct; 69(10):1027-33. PubMed ID: 24957855
[TBL] [Abstract][Full Text] [Related]
12. Functional magnetic resonance cholangiography with Gd-EOB-DTPA: a study in healthy volunteers.
Lee SW; Cha SH; Chung HH; Kim KH; Yeom SK; Seo BK; Je BK; Kim BH
Magn Reson Imaging; 2014 May; 32(4):385-91. PubMed ID: 24529920
[TBL] [Abstract][Full Text] [Related]
13. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis.
Akpinar E; Turkbey B; Karcaaltincaba M; Balli O; Akkapulu N; Balas S; Tirnaksiz B; Akata D; Akhan O
J Magn Reson Imaging; 2009 Sep; 30(3):578-85. PubMed ID: 19711404
[TBL] [Abstract][Full Text] [Related]
14. Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion.
Ringe KI; Hinrichs J; Merkle EM; Weismüller TJ; Wacker F; Meyer BC
J Magn Reson Imaging; 2014 Jul; 40(1):106-12. PubMed ID: 24923477
[TBL] [Abstract][Full Text] [Related]
15. Functional evaluation of cystic duct patency with Gd-EOB-DTPA MR imaging: an alternative to hepatobiliary scintigraphy for diagnosis of acute cholecystitis?
Krishnan P; Gupta RT; Boll DT; Brady CM; Husarik DB; Merkle EM
Abdom Imaging; 2012 Jun; 37(3):457-64. PubMed ID: 21870116
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
17. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
18. Value of gadoxetate biliary transit time in determining hepatocyte function.
Wu J; Li H; Lin Y; Chen Z; Zhong Q; Gao H; Fu L; Sandrasegaran K
Abdom Imaging; 2015 Jan; 40(1):95-101. PubMed ID: 25056714
[TBL] [Abstract][Full Text] [Related]
19. Gadoxetate Disodium-Enhanced MR Cholangiography for Evaluation of Biliary-Enteric Anastomoses: Added Value Beyond Conventional T2-Weighted Images.
Boraschi P; Donati F; Pacciardi F; Cervelli R; Gigoni R; Porcu L; Torri V
AJR Am J Roentgenol; 2019 Sep; 213(3):W123-W133. PubMed ID: 31063422
[No Abstract] [Full Text] [Related]
20. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.
Yamada A; Hara T; Li F; Fujinaga Y; Ueda K; Kadoya M; Doi K
Radiology; 2011 Sep; 260(3):727-33. PubMed ID: 21712472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
